These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1583623)

  • 1. Biochemical characterization of a subtype pancreatic cholecystokinin receptor and of its agonist binding domain.
    Poirot SS; Dufresne M; Jiménez J; Vaysse N; Fourmy D
    J Recept Res; 1992; 12(2):233-53. PubMed ID: 1583623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
    Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N
    Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recognition of affinity-labelled cholecystokinin receptor.
    Dufresne M; Poirot S; Jimenez J; Cuber JC; Vaysse N; Fourmy D
    Eur J Biochem; 1990 Jul; 191(1):141-6. PubMed ID: 2379496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of A-subtype pancreatic cholecystokinin receptor by immunoaffinity chromatography.
    Dufresne M; Poirot S; Jimenez J; Vaysse N; Fourmy D
    Biochimie; 1992 Feb; 74(2):149-51. PubMed ID: 1581390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electric properties of photoaffinity-labelled pancreatic A-subtype cholecystokinin.
    Jiménez J; Dufresne M; Poirot S; Vaysse N; Fourmy D
    J Chromatogr; 1990 Jul; 511():333-9. PubMed ID: 2211916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor.
    Pearson RK; Miller LJ; Hadac EM; Powers SP
    J Biol Chem; 1987 Oct; 262(28):13850-6. PubMed ID: 3654639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of photoaffinity probes containing poly(ethylene glycol) spacers for topographical mapping of the cholecystokinin receptor complex.
    Powers SP; Foo I; Pinon D; Klueppelberg UG; Hedstrom JF; Miller LJ
    Biochemistry; 1991 Jan; 30(3):676-82. PubMed ID: 1899032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
    Klueppelberg UG; Molero X; Barrett RW; Miller LJ
    Mol Pharmacol; 1990 Aug; 38(2):159-63. PubMed ID: 2200953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease peptide mapping of affinity-labeled rat pancreatic cholecystokinin-binding proteins.
    Klueppelberg UG; Powers SP; Miller LJ
    Biochemistry; 1989 Aug; 28(17):7124-9. PubMed ID: 2819053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cholecystokinin receptors in toad retina.
    Bone EA; Rosenzweig SA
    Peptides; 1988; 9(2):373-81. PubMed ID: 3131747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V; Philouze-Rome V; Le Huerou-Luron I; Formal M; Vaysse N; Gespach C; Guilloteau P; Fourmy D
    Endocrinology; 1993 Sep; 133(3):1182-91. PubMed ID: 8365360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of the pancreatic cholecystokinin receptor.
    Szecowka J; Hallden G; Goldfine ID; Williams JA
    Regul Pept; 1989 Mar; 24(3):215-24. PubMed ID: 2710962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of a phenethyl ester analogue of cholecystokinin to the solubilized pancreatic cholecystokinin receptor: use in ligand-affinity chromatography.
    Miller LJ; Hadac EM; Gates LK; Gaisano HY
    Biochem Biophys Res Commun; 1992 Mar; 183(2):396-404. PubMed ID: 1550549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the rat pancreatic cholecystokinin receptor.
    Duong LT; Hadac EM; Miller LJ; Vlasuk GP
    J Biol Chem; 1989 Oct; 264(30):17990-6. PubMed ID: 2808360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated.
    Pearson RK; Hadac EM; Miller LJ
    Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor.
    Klueppelberg UG; Gaisano HY; Powers SP; Miller LJ
    Biochemistry; 1989 Apr; 28(8):3463-8. PubMed ID: 2742849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches.
    Miller LJ
    Yale J Biol Med; 1992; 65(5):441-8; discussion 465-9. PubMed ID: 1340061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labeling the bovine gallbladder cholecystokinin receptor using a battery of probes.
    Schjoldager B; Powers SP; Miller LJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G579-86. PubMed ID: 3056035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.